drugset / Trial / NCT01176058

A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis

NCT01176058

Phase 3 Terminated 17 enrolled Pfizer
RandomizedParallel-groupOpen-label

Summary

In the treatment of patients with candidemia and/or other forms of invasive candidiasis , Anidulafungin is at least as effective and safe as Fluconazole.

Timeline

Start
2010-12
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Anidulafungin Other / unclassified 100 mg Intravenous
Comparator Fluconazole Small molecule 400 mg Intravenous

Indications